ECTO-NOX (ENOX) proteins of the cell surface lack thioredoxin reductase activity

BioFactors

Volumn 34, Issue 3, 2008, Pages 245-251

  Bosneaga, Elena ^a   Kim, Chinpal ^a   Shen, Bernard ^a   Watanabe, Takahiro ^a   Morre, Dorothy M ^b   Morré, D James ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); DITHIOTHREITOL; ENOX PROTEIN; INSULIN; PROTEIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SERUM ALBUMIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

CELL SURFACE; CONFERENCE PAPER; ENZYME ACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TURBIDITY;

EID: 70249098477     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520340309     Document Type: Conference Paper

References (21)

1. S. Akterin, R.F. Cowburn, A. Miranda-Vizuete, A. Jimenez, N. Bogdanovic, B. Winblad and A. Cedazo-Minguez, Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease, Cell Death and Differentiation 13 (2005), 1454-1465.
2. E.S. Arner, L. Zhong and A. Holmgren, Preparation and assay of mammalian thioredoxin and thioredoxin reductase,́ Methods Enzymol 300 (1999), 226-239.
3. E.S. Arner and A. Holmgren, Physiological functions of thioredoxin and thioredoxin reductase, Euopean Journal of Biochemistry 267 (2000), 6102-6109.
4. E.S. Arner and A. Holmgren, The thioredoxin system in cancer-introduction to a thematic volume of Seminars in Cancer Biology, Seminars in Cancer Biology 16 (2006), 419.
5. M. Berggren, A. Gallegos, J.R. Gasdaska, P.Y. Gasdaska, J. Warneke and G. Powis, Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia, Anticancer Research 16 (1996), 3459-3466.
6. A. Del Castillo-Olivares, F. Yantiri, P.-J. Chueh, S. Wang, M. Sweeting, D. Sedlak, D.M. Morre, J. Burgess and D.J.́ Morré, A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa cells,́ Arch Biochem Biophys 358 (1998), 125-140.
7. S. Fujii, Y. Nanbu, H. Nonogaki, I. Konishi, T. Mori, H. Masutani and J. Yodoi, Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium, Cancer 68 (1991), 1583-1591.
8. P.Y. Gasdaska, J.E. Oblong, I.A. Cotgreave and G. Powis, The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors, Biochimica et Biophysica Acta 1218 (1994), 292-296.
9. T.M. Grogan, C. Fenoglio-Prieser, R. Zeheb, W. Bellamy, Y. Frutiger, E. Vela, G. Stemmerman, J. Macdonald, L. Richter, A. Gallegos and G. Powis, Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival, Hum Pathol 31 (2000), 475-481.
10. A. Holmgren and P. Reichard, Thioredoxin 2: cleavage with cyanogen bromide, Eur J Biochem 2 (1967), 187-196.
11. A. Holmgren, Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action, The Journal of Biological Chemistry 254 (1979), 9113-9119.
12. A. Holmgren, Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide, The Journal of Biological Chemistry 254 (1979), 9627-9632.
13. A. Holmgren, Thioredoxin, Annual Review of Biochemistry 54 (1985), 237-271.
14. Q. Hua and M.A. Weiss, Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate, J Biol Chem 279 (2004), 21449-21460.
15. M.A. Lovell, C. Xie, S.P. Gabbita and W.R. Markesbery, Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain, Free Radical Biology and Medicne 28 (2000), 418-427.
16. H. Masutani, M. Naito, K. Takahashi, T. Hattori, A. Koito, K. Takatsuki, T. Go, H. Nakamura, S. Fujii, Y. Yoshida et al., Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients, AIDS Research of Human Retroviruses 8 (1992), 1707-1715.
17. D.J. Morre and D.M. Morŕ e, Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-́ keeping, growth, aging and neurodegenerative diseases, Free Radical Res 37 (2003), 795-808.
18. H. Nakamura, S. DeRosa, M. Roedere, M.T. Anderson, J.G. Dubs, J. Yodoi, A. Holmgren, L.A. Herzenberg and L.A. Herzenberg, Elevation of plasma thioredoxin levels in HIV-infected individuals, Inernational Immunology 8 (1996), 603-611.
19. K.U. Schallreuter, M. Jänner, H. Mensing, E.W. Breitbart, J. Berger and J.M. Wood, Thioredoxin reductase activity at ̈the surface of human primary cutaneous melanomas and their surrounding skin, Int J Cancer 48 (1991), 15-19.
20. K. Schulze-Osthoff, H. Schenk and W. Droge, Effects of thioredoxin on activation of transcription factor NF-kappa B, Methods in Enzymology 252 (1995), 253-264.
21. T. Yoshida, H. Nakamura, H. Masutani and J. Yodoi, The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process, Annals of the New York Academy of Science 1055 (2005), 1-12.